Log in

Vaxart News Headlines (NASDAQ:VXRT)

$0.37
-0.01 (-2.60 %)
(As of 10/21/2019 08:49 AM ET)
Today's Range
$0.37
Now: $0.37
$0.38
50-Day Range
$0.27
MA: $0.51
$0.75
52-Week Range
$0.25
Now: $0.37
$5.00
Volume190,866 shs
Average Volume1.60 million shs
Market Capitalization$5.91 million
P/E RatioN/A
Dividend YieldN/A
Beta0.57

Headlines

Vaxart (NASDAQ VXRT) News Headlines

Source:
DateHeadline
Curis (NASDAQ:CRIS) and Vaxart (NASDAQ:VXRT) Head to Head SurveyCuris (NASDAQ:CRIS) and Vaxart (NASDAQ:VXRT) Head to Head Survey
www.americanbankingnews.com - October 19 at 3:09 AM
Vaxart Inc (NASDAQ:VXRT) Sees Large Increase in Short InterestVaxart Inc (NASDAQ:VXRT) Sees Large Increase in Short Interest
www.americanbankingnews.com - October 11 at 8:38 PM
Vaxart Inc (NASDAQ:VXRT) Major Shareholder Acquires $203,040.00 in StockVaxart Inc (NASDAQ:VXRT) Major Shareholder Acquires $203,040.00 in Stock
www.americanbankingnews.com - October 9 at 11:21 AM
Contrasting Vaxart (NASDAQ:VXRT) & Organovo (NASDAQ:ONVO)Contrasting Vaxart (NASDAQ:VXRT) & Organovo (NASDAQ:ONVO)
www.americanbankingnews.com - October 8 at 10:13 AM
Vaxart Inc (NASDAQ:VXRT) Major Shareholder Armistice Capital Master Fund Buys 436,000 SharesVaxart Inc (NASDAQ:VXRT) Major Shareholder Armistice Capital Master Fund Buys 436,000 Shares
www.americanbankingnews.com - October 7 at 8:49 PM
Vaxart to Present Clinical Data From its Norovirus Phase 1b Study at Three Global Healthcare Conferences in October 2019Vaxart to Present Clinical Data From its Norovirus Phase 1b Study at Three Global Healthcare Conferences in October 2019
finance.yahoo.com - October 1 at 2:51 PM
Wouter Latour Acquires 166,667 Shares of Vaxart Inc (NASDAQ:VXRT) StockWouter Latour Acquires 166,667 Shares of Vaxart Inc (NASDAQ:VXRT) Stock
www.americanbankingnews.com - October 1 at 2:29 PM
Armistice Capital Master Fund Purchases 7,333,333 Shares of Vaxart Inc (NASDAQ:VXRT) StockArmistice Capital Master Fund Purchases 7,333,333 Shares of Vaxart Inc (NASDAQ:VXRT) Stock
www.americanbankingnews.com - October 1 at 2:28 PM
Vaxart Inc (NASDAQ:VXRT) Short Interest UpdateVaxart Inc (NASDAQ:VXRT) Short Interest Update
www.americanbankingnews.com - September 27 at 1:37 AM
Vaxart Announces Pricing of $8 Million Underwritten Public OfferingVaxart Announces Pricing of $8 Million Underwritten Public Offering
finance.yahoo.com - September 26 at 4:43 PM
Vaxart’s Tableted Oral Bivalent Norovirus Vaccine Meets Primary and Secondary Endpoints in Phase 1b StudyVaxart’s Tableted Oral Bivalent Norovirus Vaccine Meets Primary and Secondary Endpoints in Phase 1b Study
finance.yahoo.com - September 25 at 5:38 PM
Do Institutions Own Vaxart, Inc. (NASDAQ:VXRT) Shares?Do Institutions Own Vaxart, Inc. (NASDAQ:VXRT) Shares?
finance.yahoo.com - September 20 at 3:07 AM
Vaxart to Present at the H.C. Wainwright 21st Annual Global Investment ConferenceVaxart to Present at the H.C. Wainwright 21st Annual Global Investment Conference
finance.yahoo.com - September 4 at 8:21 AM
Vaxart Announces Second Quarter 2019 Financial Results and Provides Corporate UpdateVaxart Announces Second Quarter 2019 Financial Results and Provides Corporate Update
finance.yahoo.com - August 8 at 4:25 PM
Those Who Purchased Vaxart (NASDAQ:VXRT) Shares A Year Ago Have A 77% Loss To Show For ItThose Who Purchased Vaxart (NASDAQ:VXRT) Shares A Year Ago Have A 77% Loss To Show For It
finance.yahoo.com - July 17 at 3:57 PM
Vaxart to Present at ASM Microbe 2019Vaxart to Present at ASM Microbe 2019
finance.yahoo.com - June 20 at 11:17 AM
New Publication in Vaccine Highlights Preclinical Results of Vaxart’s Mucosal Chikungunya VaccineNew Publication in Vaccine Highlights Preclinical Results of Vaxart’s Mucosal Chikungunya Vaccine
finance.yahoo.com - May 29 at 11:09 AM
Vaxart Announces First Quarter 2019 Financial Results and Provides Corporate UpdateVaxart Announces First Quarter 2019 Financial Results and Provides Corporate Update
finance.yahoo.com - May 9 at 4:14 PM
Have Insiders Been Buying Vaxart, Inc. (NASDAQ:VXRT) Shares?Have Insiders Been Buying Vaxart, Inc. (NASDAQ:VXRT) Shares?
finance.yahoo.com - May 7 at 4:15 PM
Vaxart (VXRT) Reports First Patient in Randomized Cohort of Bivalent Norovirus Vaccine Phase 1b Clinical Trial - StreetInsider.comVaxart (VXRT) Reports First Patient in Randomized Cohort of Bivalent Norovirus Vaccine Phase 1b Clinical Trial - StreetInsider.com
www.streetinsider.com - April 16 at 6:14 PM
Vaxart Doses First Patient in Randomized Cohort of Bivalent Norovirus Vaccine Phase 1b Clinical TrialVaxart Doses First Patient in Randomized Cohort of Bivalent Norovirus Vaccine Phase 1b Clinical Trial
finance.yahoo.com - April 16 at 6:14 PM
Vaxart to Present at the 29th European Congress of Clinical Microbiology & Infectious DiseasesVaxart to Present at the 29th European Congress of Clinical Microbiology & Infectious Diseases
finance.yahoo.com - April 12 at 1:29 PM
Vaxart Announces Pricing of Underwritten Public OfferingVaxart Announces Pricing of Underwritten Public Offering
finance.yahoo.com - April 9 at 1:00 PM
Vaxart to Present at Global Medical Meetings in AprilVaxart to Present at Global Medical Meetings in April
finance.yahoo.com - March 28 at 12:20 PM
Vaxart Completes Dosing of the Lead-In Cohort in Bivalent Norovirus Vaccine Phase 1b Clinical TrialVaxart Completes Dosing of the Lead-In Cohort in Bivalent Norovirus Vaccine Phase 1b Clinical Trial
finance.yahoo.com - March 27 at 12:28 PM
What A $30,000 Losing Trade Looks Like, And How To Bounce BackWhat A $30,000 Losing Trade Looks Like, And How To Bounce Back
finance.yahoo.com - March 23 at 12:21 PM
Vaxart Announces Closing of Registered Direct Offering of Common Stock - Business WireVaxart Announces Closing of Registered Direct Offering of Common Stock - Business Wire
www.businesswire.com - March 21 at 4:13 PM
Vaxart +16% on launch of norovirus vaccine study - Seeking AlphaVaxart +16% on launch of norovirus vaccine study - Seeking Alpha
seekingalpha.com - March 21 at 4:13 PM
Vaxart Announces Closing of Registered Direct Offering of Common StockVaxart Announces Closing of Registered Direct Offering of Common Stock
finance.yahoo.com - March 20 at 4:23 PM
Vaxart Announces $3 Million Registered Direct Offering Priced At-the-MarketVaxart Announces $3 Million Registered Direct Offering Priced At-the-Market
www.marketwatch.com - March 19 at 4:21 PM
Vaxart Announces Initiation of Bivalent Norovirus Vaccine Phase 1b Clinical TrialVaxart Announces Initiation of Bivalent Norovirus Vaccine Phase 1b Clinical Trial
finance.yahoo.com - March 19 at 12:05 PM
Vaxart Announces Fourth Quarter and Year-End 2018 Financial Results and Provides Corporate UpdateVaxart Announces Fourth Quarter and Year-End 2018 Financial Results and Provides Corporate Update
finance.yahoo.com - February 7 at 11:31 AM
Vaxart to Present at World Vaccine and Immunotherapy Congress West Coast 2018Vaxart to Present at World Vaccine and Immunotherapy Congress West Coast 2018
finance.yahoo.com - November 28 at 11:05 AM
Vaxart Announces Third Quarter 2018 Financial Results and Provides Corporate UpdateVaxart Announces Third Quarter 2018 Financial Results and Provides Corporate Update
finance.yahoo.com - November 9 at 11:00 AM
Vaxart’s Flu Vaccine Looks Promising, But Its Future Is UncertainVaxart’s Flu Vaccine Looks Promising, But Its Future Is Uncertain
finance.yahoo.com - October 16 at 10:23 AM
Vaxarts Flu Vaccine Superior to Sanofis Fluzone, Shares UpVaxart's Flu Vaccine Superior to Sanofi's Fluzone, Shares Up
finance.yahoo.com - October 5 at 3:28 PM
Today’s Research Reports on Stocks to Watch: Guardant Health and VaxartToday’s Research Reports on Stocks to Watch: Guardant Health and Vaxart
finance.yahoo.com - October 5 at 10:16 AM
Vaxart's stock soars after upbeat results from oral flu vaccine trialVaxart's stock soars after upbeat results from oral flu vaccine trial
finance.yahoo.com - October 4 at 3:28 PM
Vaxarts stock soars after upbeat results from oral flu vaccine trialVaxart's stock soars after upbeat results from oral flu vaccine trial
www.marketwatch.com - October 4 at 10:04 AM
New Data from Phase 2 Flu Challenge Study Demonstrates Vaxart’s Oral H1 Flu Vaccine Generated Protective Mucosal ImmunityNew Data from Phase 2 Flu Challenge Study Demonstrates Vaxart’s Oral H1 Flu Vaccine Generated Protective Mucosal Immunity
finance.yahoo.com - October 4 at 10:04 AM
Vaxart Announces Second Quarter 2018 Financial Results and Corporate UpdateVaxart Announces Second Quarter 2018 Financial Results and Corporate Update
finance.yahoo.com - August 9 at 10:52 AM
Vaxart Announces Publication of the Phase 1 Results of its Oral Norovirus Tablet Vaccine in Journal of Clinical Investigation InsightVaxart Announces Publication of the Phase 1 Results of its Oral Norovirus Tablet Vaccine in Journal of Clinical Investigation Insight
finance.yahoo.com - July 12 at 10:04 AM
Oral RSV Vaccine - Preclinical Data Published in VaccineOral RSV Vaccine - Preclinical Data Published in Vaccine
finance.yahoo.com - June 27 at 9:42 AM
Vaxart Reports Topline Results from Phase 2 Trial of Teslexivir™ for the Treatment of CondylomaVaxart Reports Topline Results from Phase 2 Trial of Teslexivir™ for the Treatment of Condyloma
finance.yahoo.com - June 4 at 8:53 AM
Vaxart to Present at ASM Microbe 2018Vaxart to Present at ASM Microbe 2018
finance.yahoo.com - June 1 at 8:57 AM
Vaxart to Present at the Jefferies 2018 Global Healthcare ConferenceVaxart to Present at the Jefferies 2018 Global Healthcare Conference
finance.yahoo.com - June 1 at 8:57 AM
Was Vaxart Inc’s (NASDAQ:VXRT) Earnings Growth Better Than The Industry’s?Was Vaxart Inc’s (NASDAQ:VXRT) Earnings Growth Better Than The Industry’s?
finance.yahoo.com - May 31 at 3:23 PM
Vaxart Announces First Quarter 2018 Financial Results and Corporate UpdateVaxart Announces First Quarter 2018 Financial Results and Corporate Update
finance.yahoo.com - May 16 at 8:22 AM
Vaxart Announces $5 Million Inavir® Revenue MilestoneVaxart Announces $5 Million Inavir® Revenue Milestone
finance.yahoo.com - April 20 at 3:21 PM
Vaxart Appoints Brant Biehn as Senior Vice President, Commercial OperationsVaxart Appoints Brant Biehn as Senior Vice President, Commercial Operations
finance.yahoo.com - April 19 at 3:22 PM
This page was last updated on 10/21/2019 by MarketBeat.com Staff

Featured Article: Percentage Gainers

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel